title: Does biotech M&A benefit investors?
authors.affiliation: tom@completegrowth.com
authors.forename: Tom
authors.initials: T
authors.lastname: Jacobs
mesh_terms: D001709:Biotechnology / Q000191:economics / Q000458:organization & administration* / Q000706:statistics & numerical data; D002202:Capital Financing / Q000191:economics* / Q000379:methods* / Q000458:organization & administration / Q000706:statistics & numerical data; D004345:Drug Industry / Q000191:economics / Q000458:organization & administration* / Q000706:statistics & numerical data; D007373:Interinstitutional Relations; D007449:Investments / Q000191:economics* / Q000458:organization & administration / Q000706:statistics & numerical data; D010067:Ownership / Q000191:economics* / Q000458:organization & administration / Q000706:statistics & numerical data; D014481:United States